For Caregivers
Caring for Yourself: Information for Caregivers
People living with ALS require increasing levels of care as their disease progresses. Most of the time, responsibility for personal care is taken on by caregivers such as family and friends.
Advocacy
ALS Canada Advocacy in a Box Toolkit
A resource that supports and empowers advocacy efforts aimed at improving the lives of people living with ALS (Amyotrophic Lateral Sclerosis).
Volunteering & Giving
Annual Report 2023: Supporting the ALS community
Living with ALS can have many challenges, but with the support of the community, people living with the disease can navigate their journey with greater ease.
Advocacy
Annual report 2023: Empowering informed decisions
ALS Canada’s work is empowered by community. Discover how, in 2023, our work within the ALS community helped people affected by the disease feel empowered and informed to make decisions and engage in advocacy efforts.
Events
Annual Report 2023: Bringing the community together
Walk, ride, or pull – no challenge is too big when it comes to supporting a world free of ALS
Research
Annual Report 2023: Improving quality of life
ALS Canada’s work is empowered by community. Discover how, in 2023, our collaboration with clinicians and investments in research aims to enhance care and the potential for future treatments.
Advocacy
Together we are stronger: The ALS community takes to Ottawa
In early March, members of the ALS community joined ALS Canada in Ottawa for two days of advocacy training and meetings with politicians and other government officials.
Events
2024 ALS Canada Research Forum
Bringing together researchers and community members to move the needle on ALS treatment and innovation
Research
ALS Canada Research Glossary
This glossary contains a list of scientific and medical terms and definitions that are relevant to amyotrophic lateral sclerosis (ALS).
Events
United in ALS this June ALS Awareness Month
ALS Society of Canada rallying the community together to bring awareness to nearly 4,000 Canadians living with ALS and their families.
Research
Canadians living with ALS unite to CAPTURE ALS
Amyotrophic lateral sclerosis (ALS) is a complex disease with varying symptoms and severity for people affected. Due to its heterogeneity, diagnosing the disease can be challenging and finding effective treatments can also be difficult.
Advocacy
Ontario Provincial ALS Program: Enhancing care and quality of life of people living with ALS
In Canada, what the provincial health care systems provide does not always match the needs of people living with ALS. This statement rings true for Ontario, where the current ALS care and support landscape in the province presents people living with ALS with significant challenges that demand immediate action.
Fund Development
You can support ALS Canada & enjoy tax benefits!
As we bid farewell to 2023, we want to take a moment to celebrate YOU. Your dedication throughout this month, and indeed the entire year, has been nothing short of inspirational.
Fund Development
We’re closer than ever…but we’re not there yet
A letter from Tammy Moore, ALS Canada’s Chief Executive Officer
Volunteering & Giving
An exciting GivingTuesday announcement!
When it comes to fundraising for ALS, next Tuesday (November 28) is the single most important day of the year, and to help us celebrate the day, we have an exciting announcement. Does this sound intriguing? Keep reading….
Research
ALS Canada and Brain Canada invest more than half a million dollars in the future of ALS researchers with the 2023 Clinical Research Fellowship and Trainee Awards
Toronto — In recognition of World Science Day, together with Brain Canada, the ALS Society of Canada (ALS Canada) is pleased to announce the 2023 ALS Canada-Brain Canada Clinical Research Fellowship and Trainee Award recipients. These early career grants are designed to support the training and research of clinicians in clinical care and PhD students and postdoctoral fellows engaged in research related to amyotrophic lateral sclerosis (ALS) across Canada.
Research
Can we reprogram cells we already have to replace neurons damaged by ALS? This postdoctoral fellow wants to find out
Dr. Hussein Ghazale is the recipient of a $165,000 ALS Canada – Brain Canada 2022 Trainee Award.
After finishing his PhD in France, Dr. Ghazale moved to Canada to work with Dr. Carol Schuurmans at Sunnybrook Research Institute. Her team examines if neuronal reprogramming could serve as a potential treatment strategy for neurodegenerative diseases, including ALS.
Research
PhD student Lucia Jadon opens new pathways for ALS research
PhD student Lucia Meng Qi Jadon (previously Liao) is the recipient of a $75,000 ALS Canada – Brain Canada 2022 Trainee Award. She will use the funding to investigate whether a newly discovered tag on TDP-43 might have an important role to play in ALS.